explore -WSS

explore

author：Wikipedia 2025-09-30 23:07:39 - browse：117

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Why a market frenzy over new weight loss drugs defies logic

hotspot

WSS

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Roche acquires Telavant from Roivant, adding experimental IBD treatment

UnitedHealth, Optum discontinue NaviHealth name

STAT Readout: Friday, Oct. 20 biotech updates

Trump demands the U.S. pay no more for drugs than other countries … again

Drug repurposing or repositioning? The language matters

leisure time

explore

MORE: General Motors recalls over 600K cars due to car seat safety issue

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Roche drug slashes death risk in early

What does generative AI mean for health care? We asked experts

Why a market frenzy over new weight loss drugs defies logic

Sports medicine is finally prioritizing gender equality

CZI to create biohub to build anti

The cancer drug shortage isn’t new — and neither are the solutions

Anesthesiologist group: stop taking Ozempic before surgery

Moonlake's readout produced a cash windfall. Risks remain

STAT Readout: Friday, Oct. 20 biotech updates

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Apple is now the first public company to be valued at $3 trillion

Affirmative action in medical school literally saved lives

STAT Readout: Friday, Oct. 20 biotech updates

STAT Readout Newsletter: Biotech news today

Cassava Sciences’ Alzheimer’s clinical trials should be halted

focus

hotspot

entertainment

leisure time